Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.

Berger Montague investigates Hims and Hers after stock drops 26% following Novo Nordisk's termination of GLP-1 drug partnership.

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a ...

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...

In the May 11 Instagram Reel, Berry promoted her Let's Spin intimacy gel with a video of herself and her 55-year-old boyfriend Van Hunt under the sheets in a hotel bed in Cannes.

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its ...

Hims & Hers Health, Inc. has a fifty-two week low of $13.47 and a fifty-two week high of $72.98. The firm has a market cap of $13.67 billion, a price-to-earnings ratio of 88.54, a P/E/G ratio of 2 ...

Kristin Cavallari’s three kids are stepping into the spotlight on her new reality show — and they’re not afraid to comment on her dating choices. During the Wednesday, June 18, episode of ...

Hims & Hers Health has a 52-week low of $13.47 and a 52-week high of $72.98. Hims & Hers Health (NYSE:HIMS – Get Free Report) last released its earnings results on Monday, May 5th.

Hims & Hers Health's acquisition of ZAVA fast-tracks its entry into Europe's weight-loss market, expanding its subscriber base by 54%. The deal is attractively priced, non-dilutive, and leverages ...